• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    171.94 Up 3.37(2.00%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:168.57
    Open:167.69
    Bid:171.50 x 100
    Ask:N/A
    1y Target Est:214.16
    Beta:1.18
    Earnings Date:Jul 22 - Jul 27 (Est.)
    Day's Range:167.31 - 172.65
    52wk Range:150.06 - 203.30
    Volume:2,570,610
    Avg Vol (3m):1,731,470
    Market Cap:34.32B
    P/E (ttm):58.90
    EPS (ttm):2.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNUp 2.00%34.32B
    AMGNDown 0.16%124.37B
    BAXDown 0.25%36.67B

    Key Statistics

    Forward P/E (1 yr):29.64
    P/S (ttm):14.84
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.94
    Quarterly EPS Est (Jun-15) :1.38
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):2.26

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback